Abstract
A 3D-model of bovine testicular hyaluronidase (BTH) was constructed based on established tertiary structure of human hyaluronidase Hyal1 using a molecular homological modeling method in silico. The analysis of the BTH 3D-model demonstrated lysine residue stratification during enzyme modification. The 3D-model of chondroitin sulfate (CHS)-modified hyaluronidase (BTH-CHS) was obtained by modeling covalent binding of lysine residues with benzoquinone-activated CHS. The degree of enzyme modification and the length of CHS chains were varied during 3D modeling. The importance of deep BTH modification degree for the formation of active and stable enzyme derivatives was shown, as determined earlier experimentally. The effective size of the CHS coat for productive BTH modification was confirmed. It is theoretically achieved at the increase in molecular mass of BTH-CHS derivative to approximately 140–180 kDa and can be practically obtained, according to experimental data, using CHS of different molecular mass (30–50 as well as 120–140 kDa).
Similar content being viewed by others
Abbreviations
- BTH:
-
bovine testicular hyaluronidase
- CHS:
-
chondroitin sulfate
- 3D:
-
spatial/three-dimensional/tertiary protein structure
- EGF:
-
epidermal growth factor
- GCU:
-
glucuronic acid
- Hyal1:
-
human hyaluronidase
- NAG:
-
N-acetylglucosamine
- RMS:
-
root mean square deviation of model Cα-atoms from prototype Cα-atoms
- TNBS:
-
trinitrobenzenesulfonic acid
References
Maksimenko, A. V. (2012) Cardiological biopharmaceutics in concept of targeted drug transport: practical results and research perspectives, Acta Naturae, 4, 76–86.
Batool, S., Ferdous, S., Kamal, M. A., Iftikhar, H., and Rashid, S. (2013) In silico screening for identification of novel Aurora kinase inhibitors by molecular docking, dynamics simulations and ligand-based hypothesis approaches, Enz. Eng., 2, 1.
Wu, Z. L. (2012) Time for molecular glycobiology, J. Glycobiol., 1, e106.
Maksimenko, A. V., and Turashev, A. D. (2012) No-reflow phenomenon and endothelial glycocalyx of microcirculation, Biochem. Res. Int., 2012, 859231; DOI: 10.1155/2012/859231.
Reitsma, S., Slaaf, D. W., Vink, H., van Zandvoort, M. A., and oude Egbrink, M. G. A. (2007) The endothelial glycocalyx: compositions, functions, and visualization, Pflugers Arch., 454, 345–359.
Rubio-Gayosso, I., Platts, S. H., and Duling, B. R. (2006) Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury, Am. J. Physiol. Heart Circ. Physiol., 290, 2247–2256.
Stern, R., and Jedrzejas, M. J. (2006) Hyaluronidases: their genomics, structure, and mechanism of action, Chem. Rev., 106, 818–839.
Vink, H., and Duling, B. R. (2000) Capillary endothelial surface layer selectively reduces plasma solute distribution volume, Am. J. Physiol. Heart Circ. Physiol., 278, 285–289.
Platts, S. H., and Duling, B. R. (2004) Adenosine A3 receptor activation modulates the capillary endothelial glycocalyx, Circ. Res., 94, 77–82.
Stern, R. (2008) Hyaluronidases in cancer biology, Sem. Cancer Biol., 18, 275–280.
Toole, B. P., Wight, T. N., and Tammi, M. I. (2002) Hyaluronan-cell interactions in cancer and vascular disease, J. Biol. Chem., 277, 4593–4596.
Stern, R., and Jedrzejas, M. J. (2008) Carbohydrate polymer at the center of life’s origins: the importance of molecular processivity, Chem. Rev., 108, 5061–5085.
Erickson, M., and Stern, R. (2012) Chain gangs: new aspects of hyaluronan metabolism, Biochem. Res. Int., 2012, 893947; DOI: 10.1155/2012/893947.
Markovich-Housley, Z., Miglierini, G., Soldatova, L., Rizkallah, P. J., Muller, U., and Schirmer, T. (2000) Crystal structure of hyaluronidase, a major allergen of bee venom, Structure, 8, 1025–1035.
Chao, K. L., Muthukumar, L., and Herzberg, O. (2007) Structure of human hyaluronidase-1, a hyaluronan hydrolyzing enzyme involved in tumor growth and angiogenesis, Biochemistry, 46, 6911–6920.
Maksimenko, A. V., Schechilina, U. V., and Tischenko, E. G. (2001) Dextran modified hyaluronidase is resistant to heparin inhibition, Biochemistry (Moscow), 66, 456–463.
Maksimenko, A. V., Schechilina, U. V., and Tischenko, E. G. (2003) Glycosaminoglycan microsurrounding of hyaluronidase in regulation of its endoglycosidase activity, Biochemistry (Moscow), 68, 862–868.
Schwede, T., Kopp, J., Guex, N., and Peitsch, M. C. (2003) Swiss-model: an automated protein homologymodeling server, Nucleic Acids Res., 31, 3381–3385.
Arnold, K., Bordoli, L., Kopp, J., and Schwede, T. (2006) The Swiss-model workspace: a web-based environment for protein structure homology modeling, Bioinformatics, 22, 195–201.
Schindyalov, I. N., and Bourne, P. E. (1998) Protein structure alignment by incremental combinatorial extension (CE) of the optimal path, Protein Eng., 11, 739–747.
Laskovski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. (1993) Procheck: a program to check the stereochemical quality of protein structures, J. Appl. Crystal., 26, 283–291.
Morris, A. L., MacArthur, M. W., Hutchinson, E. G., and Thornton, J. M. (1992) Stereochemical quality of protein structure coordinates, Proteins, 12, 345–364.
Vriend, G. (1990) WHAT IF: a molecular modeling and drug design program, J. Mol. Graph., 8, 52–56.
Melo, F., Devos, D., Depiereux, E., and Feytmans, E. (1997) Anolea: a www server to assess protein structures, Proc. Int. Conf. Intel. Syst. Mol. Biol., 5, 187–190.
Melo, F., and Feytmans, E. (1998) Assessing protein structures with a non-local atomic interaction energy, J. Mol. Biol., 277, 1141–1152.
Melo, F., and Feytmans, E. (1997) Novel knowledge-based mean force potential at atomic level, J. Mol. Biol., 267, 207–222.
Maksimenko, A., Turashev, A., Fedorovich, A., Rogoza, A., and Tischenko, E. (2013) Hyaluronidase proof for endothelial glycocalyx as partaker of microcirculation disturbances, J. Life Sci., 7, 171–188.
Turashev, A. D., Tischenko, E. G., and Maksimenko, A. V. (2009) Glycation of native and chondroitin sulfate-modified hyaluronidase by monosaccharides, Mol. Med., 3, 51–56.
Belem-Goncalves, S., Tsan, P., Lancelin, J.-M., Alves, T. L. M., Salim, V. M., and Besson, F. (2006) Interfacial behavior of bovine testis hyaluronidase, Biochem. J., 398, 569–576.
Botzki, A., Rigden, D. J., Braun, S., Nukui, M., Salmen, S., Hoechstetter, J., Bernhardt, G., Dove, S., Jedrzejas, M. J., and Buschauer, A. (2004) L-ascorbic acid G-hexadecanoate, a potent hyaluronidase inhibitor. X-ray structure and molecular modeling of enzyme-inhibitor complexes, J. Biol. Chem., 279, 45990–45997.
Zhang, L., Bharadwaj, A. G., Casper, A., Barkley, J., Barycki, J. J., and Simpson, M. A. (2009) Hyaluronidase activity of human Hyal1 requires active site acidic and tyrosine residues, J. Biol. Chem., 284, 9433–9442.
Hofinger, E. S., Bernhardt, G., and Buschauer, A. (2007) Kinetics of hyal-1 and PH-20 hyaluronidases: comparison of minimal substrates and analysis of the transglycosylation reaction, Glycobiology, 17, 963–971.
Dygai, A. M., Zyuz’kov, G. N., Zhdanov, V. V., Udut, E. V., Miroshnichenko, L. A., Simanina, E. V., Khrichkova, T. Yu., Minakova, M. Yu., and Madonov, P. G. (2013) Specific activity of electron-beam synthesis immobilized hyaluronidase on G-CSF induced mobilization of bone marrow progenitor cells, Stem Cell Rev. Rep., 9, 140–147.
Zuzkov, G. N., Maksimenko, A. V., Zhdanov, V. V., Udut, E. V., Turashev, A. D., Miroshnichenko, N. A., Simanina, E. V., Chaikovsky, A. V., Minakova, M. U., Artamonov, A. V., Bekarev, A. A., Madonov, P. G., Udut, V. V., and Dygai, M. M. (2013) Specific activity of chondroitin sulfate-modified hyaluronidase in relation to progenitor cell function, Klet. Tekhnol. Biol. Med., 4, 193–196.
Heldin, P., Basu, K., Olofsson, B., Porsch, H., Kozlova, I., and Kahata, K. (2013) Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer, J. Biochem., 154, 395–408.
Wang, J., Wang, W., Kollman, P. A., and Case, D. A. (2006) Automatic atom type and bond type perception in molecular mechanical calculations, J. Mol. Graph. Model., 25, 247–260.
Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., and Case, D. A. (2004) Development and testing of a general amber force field, J. Comput. Chem., 25, 1157–1174.
Maksimenko, A. V., Petrova, M. L., Tischenko, E. G., and Schechilina, Y. V. (2001) Chemical modification of hyaluronidase regulates its inhibition by heparin, Eur. J. Pharm. Biopharm., 51, 33–38.
Turashev, A. D., Tischenko, E. G., and Maksimenko, A. V. (2009) Non-enzyme glycosylation of native and chondroitin sulfate-modified hyaluronidase by disaccharides, Mol. Med., 6, 50–55.
Maksimenko, A. V. (2008) Effects of glycosaminoglycans in vascular events, Khim. Farm. Zh., 42, 3–13.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A. V. Maksimenko, A. D. Turashev, R. S. Beabealashvili, 2015, published in Biokhimiya, 2015, Vol. 80, No. 3, pp. 348–357.
Rights and permissions
About this article
Cite this article
Maksimenko, A.V., Turashev, A.D. & Beabealashvili, R.S. Stratification of chondroitin sulfate binding sites in 3D-model of bovine testicular hyaluronidase and effective size of glycosaminoglycan coat of the modified protein. Biochemistry Moscow 80, 284–295 (2015). https://doi.org/10.1134/S0006297915030049
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297915030049